Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis

Area of Science:

• Microbiology
• Immunology
• Neurology

Background:

• Streptococcus pneumoniae has over 90 serotypes based on polysaccharide capsule composition.
• While some serotypes cause carriage and others invasive disease, the severity of invasive disease by carriage serotypes is unknown.
• The direct contribution of capsule type versus other virulence factors to disease severity remains unclear.

Purpose of the Study:

• To determine the direct effect of pneumococcal capsule type on meningitis severity.
• To isolate the impact of capsule type from other genetic factors using capsule-switch mutants.
• To investigate the role of capsule in the infant rat model of pneumococcal meningitis.

Main Methods:

• Utilized a clinical isolate of Streptococcus pneumoniae and its capsule-switch mutants.
• Inoculated infant rats to establish a meningitis model.
• Assessed mortality, capsule thickness in cerebrospinal fluid (CSF), inflammatory cytokine response in CSF, and cortical brain damage.

Main Results:

• A polysaccharide capsule is essential for Streptococcus pneumoniae to cause meningitis.
• Serotype 6B demonstrated significantly higher mortality rates compared to serotype 7F.
• Increased capsule thickness in CSF, heightened inflammatory cytokine response, and greater cortical brain damage were observed with serotype 6B.

Conclusions:

• Pneumococcal capsule type directly influences the severity of meningitis.
• Capsule characteristics, such as thickness, correlate with disease outcomes.
• Findings are critical for understanding serotype replacement in the context of current vaccination strategies targeting specific capsule types.